PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN MENSTRUAL ENDOMETRIUM AND IN PRIMARY CULTURES OF ENDOMETRIAL CELLS

Citation
J. Nordengren et al., PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN MENSTRUAL ENDOMETRIUM AND IN PRIMARY CULTURES OF ENDOMETRIAL CELLS, Fibrinolysis, 10(5-6), 1996, pp. 295-302
Citations number
36
Categorie Soggetti
Hematology
Journal title
ISSN journal
02689499
Volume
10
Issue
5-6
Year of publication
1996
Pages
295 - 302
Database
ISI
SICI code
0268-9499(1996)10:5-6<295:PIIMEA>2.0.ZU;2-P
Abstract
The objective was to study content, distribution, and cyclic variation of plasminogen activator inhibitor 2 (PAI-2) in human endometrial tis sue and secretion. Regulation of PAI-2 by steroid hormones and growth factor was further studied in primary cultures of endometrial cells. E ndometrial secretion and menstrual discharge was obtained from healthy volunteers, and endometrial tissue from patients at operation. PAI-2 was assayed with an ELISA in endometrial section, menstrual discharge, tissue homogenates, and conditioned media. Furthermore, endometrial t issue was analyzed with immuno-histochemistry. PAI-2 was found in very low concentrations in extracts of normal non-pregnant human endometri um, and was released to the uterine cavity in small quantities without any difference between the proliferative and secretory phases. Also, no specific immune-staining for PAI-2 was seen in the proliferative an d secretory phases. However, in menstrual endometrium certain cells in the stroma stained positive for PAI-2, and the concentration of PAI-2 was high in menstrual blood. Endometrial cells obtained in the prolif erative, as well as in the secretory phases, contained significant amo unts of PAI-2 after three days culture. A minor fraction was released from the stromal cells, but not from the epithelial cells. Intracellul ar PAI-2 was in its low molecular weight form, while both the low and high molecular weight forms were secreted in stromal cell cultures. Tr eatment of the cell cultures with estradiol, progesterone, DH-testoste rone, epidermal growth factor, transforming growth factor alpha, and b asic fibroblast growth factor affected neither the content nor the rel ease of PAI-2. Significant levels of PAI-2 were associated only with t he menstrual phase in vivo, whereas cultured endometrial cells, obtain ed in the proliferative and secretory phases, expressed PAI-2. Thus, P AI-2 production in primary cultures of endometrial cells seems to be a n in vitro phenomenon.